Randomized Multicenter Study to Compare Starting Nevirapine at the Full Dose With Dose Escalation in Patients Who Require Efavirenz to be Withdrawn Due to Adverse Reactions
Phase of Trial: Phase IV
Latest Information Update: 02 Jun 2011
At a glance
- Drugs Nevirapine (Primary)
- Indications HIV-1 infections
- Focus Pharmacokinetics
- Acronyms VENICE
- 10 Jun 2017 Biomarkers information updated
- 18 Jul 2010 Results have been presented at the 18th International AIDS Conference.
- 10 Feb 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.